Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF Goodwill

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF posts a goodwill of $280M as of June 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF's goodwill was $0. The latest reading is $280M (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Goodwill is one piece of Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF's financial statement story. At $280M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for GERM's goodwill usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF's other metric pages and overview cover the third.